Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1999 Oct;107(Suppl 5):777–781. doi: 10.1289/ehp.99107s5777

The role of environmental factors in insulin-dependent diabetes mellitus: an unresolved issue.

M R Kraine 1, R M Tisch 1
PMCID: PMC1566241  PMID: 10502544

Abstract

Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease characterized by the destruction of the insulin-secreting beta cells found in the islets of Langerhans. Reduced beta-cell mass results in overt diabetes, requiring lifelong exogenous insulin administration and the possibility of numerous sequelae. Incidence and development of IDDM depend upon a variety of genetic and nongenetic factors. Environmental factors such as chemicals, diet, and infection are suspected to influence the development of disease. This review describes the work performed to date to elucidate the role of these environmental factors in IDDM.

Full text

PDF
777

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akerblom H. K., Knip M. Putative environmental factors in Type 1 diabetes. Diabetes Metab Rev. 1998 Mar;14(1):31–67. doi: 10.1002/(sici)1099-0895(199803)14:1<31::aid-dmr201>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  2. Alessiani M., Cillo U., Fung J. J., Irish W., Abu-Elmagd K., Jain A., Takaya S., Van Thiel D., Starzl T. E. Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc. 1993 Feb;25(1 Pt 1):628–634. [PMC free article] [PubMed] [Google Scholar]
  3. Atkinson M. A., Bowman M. A., Campbell L., Darrow B. L., Kaufman D. L., Maclaren N. K. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest. 1994 Nov;94(5):2125–2129. doi: 10.1172/JCI117567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Benoist C., Mathis D. Autoimmunity. The pathogen connection. Nature. 1998 Jul 16;394(6690):227–228. doi: 10.1038/28282. [DOI] [PubMed] [Google Scholar]
  5. Bouchard P., Sai P., Reach G., Caubarrère I., Ganeval D., Assan R. Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes. 1982 Jan;31(1):40–45. [PubMed] [Google Scholar]
  6. Carroll P. B., Rilo H., Reyes J., Alejandro R., Zeng Y., Ricordi C., Tzakis A., Shapiro R., Starzl T. E. FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication. Transplant Proc. 1991 Dec;23(6):3171–3172. [PMC free article] [PubMed] [Google Scholar]
  7. Conrad B., Weidmann E., Trucco G., Rudert W. A., Behboo R., Ricordi C., Rodriquez-Rilo H., Finegold D., Trucco M. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature. 1994 Sep 22;371(6495):351–355. doi: 10.1038/371351a0. [DOI] [PubMed] [Google Scholar]
  8. Conrad B., Weissmahr R. N., Böni J., Arcari R., Schüpbach J., Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell. 1997 Jul 25;90(2):303–313. doi: 10.1016/s0092-8674(00)80338-4. [DOI] [PubMed] [Google Scholar]
  9. Esposti M. D., Ngo A., Myers M. A. Inhibition of mitochondrial complex I may account for IDDM induced by intoxication with the rodenticide Vacor. Diabetes. 1996 Nov;45(11):1531–1534. doi: 10.2337/diab.45.11.1531. [DOI] [PubMed] [Google Scholar]
  10. Fung J. J., Alessiani M., Abu-Elmagd K., Todo S., Shapiro R., Tzakis A., Van Thiel D., Armitage J., Jain A., McCauley J. Adverse effects associated with the use of FK 506. Transplant Proc. 1991 Dec;23(6):3105–3108. [PMC free article] [PubMed] [Google Scholar]
  11. Gailani S., Nussbaum A., Onuma T., Freeman A. Diabetes in patients treated with asparaginase. Clin Pharmacol Ther. 1971 May-Jun;12(3):487–490. doi: 10.1002/cpt1971123487. [DOI] [PubMed] [Google Scholar]
  12. Harada M., Makino S. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia. 1984 Dec;27(6):604–606. doi: 10.1007/BF00276978. [DOI] [PubMed] [Google Scholar]
  13. Herold K. C., Nagamatsu S., Buse J. B., Kulsakdinun P., Steiner D. F. Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. Transplantation. 1993 Jan;55(1):186–192. doi: 10.1097/00007890-199301000-00035. [DOI] [PubMed] [Google Scholar]
  14. Horwitz M. S., Bradley L. M., Harbertson J., Krahl T., Lee J., Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med. 1998 Jul;4(7):781–785. doi: 10.1038/nm0798-781. [DOI] [PubMed] [Google Scholar]
  15. Hyöty H., Hiltunen M., Knip M., Laakkonen M., Vähäsalo P., Karjalainen J., Koskela P., Roivainen M., Leinikki P., Hovi T. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes. 1995 Jun;44(6):652–657. doi: 10.2337/diab.44.6.652. [DOI] [PubMed] [Google Scholar]
  16. Hyöty H., Hiltunen M., Lönnrot M. Enterovirus infections and insulin dependent diabetes mellitus--evidence for causality. Clin Diagn Virol. 1998 Apr;9(2-3):77–84. doi: 10.1016/s0928-0197(98)00007-5. [DOI] [PubMed] [Google Scholar]
  17. Kaprio J., Tuomilehto J., Koskenvuo M., Romanov K., Reunanen A., Eriksson J., Stengård J., Kesäniemi Y. A. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 1992 Nov;35(11):1060–1067. doi: 10.1007/BF02221682. [DOI] [PubMed] [Google Scholar]
  18. Karounos D. G., Wolinsky J. S., Thomas J. W. Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. J Immunol. 1993 Apr 1;150(7):3080–3085. [PubMed] [Google Scholar]
  19. Katz J. D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 1995 May 26;268(5214):1185–1188. doi: 10.1126/science.7761837. [DOI] [PubMed] [Google Scholar]
  20. Land V. J., Sutow W. W., Fernbach D. J., Lane D. M., Williams T. E. Toxicity of L-asparginase in children with advanced leukemia. Cancer. 1972 Aug;30(2):339–347. doi: 10.1002/1097-0142(197208)30:2<339::aid-cncr2820300206>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  21. Like A. A., Rossini A. A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science. 1976 Jul 30;193(4251):415–417. doi: 10.1126/science.180605. [DOI] [PubMed] [Google Scholar]
  22. Luppi P., Trucco M. Superantigens in insulin-dependent diabetes mellitus. Springer Semin Immunopathol. 1996;17(4):333–362. doi: 10.1007/BF01795133. [DOI] [PubMed] [Google Scholar]
  23. Malaisse W. J. Alloxan toxicity to the pancreatic B-cell. A new hypothesis. Biochem Pharmacol. 1982 Nov 15;31(22):3527–3534. doi: 10.1016/0006-2952(82)90571-8. [DOI] [PubMed] [Google Scholar]
  24. Menser M. A., Forrest J. M., Bransby R. D. Rubella infection and diabetes mellitus. Lancet. 1978 Jan 14;1(8055):57–60. doi: 10.1016/s0140-6736(78)90001-6. [DOI] [PubMed] [Google Scholar]
  25. Mosmann T. R., Coffman R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173. doi: 10.1146/annurev.iy.07.040189.001045. [DOI] [PubMed] [Google Scholar]
  26. Moxey-Mims M. M., Kay C., Light J. A., Kher K. K. Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506) Transplantation. 1998 Mar 15;65(5):617–619. doi: 10.1097/00007890-199803150-00003. [DOI] [PubMed] [Google Scholar]
  27. Notkins A. L. Virus-induced diabetes mellitus. Arch Virol. 1977;54(1-2):1–17. doi: 10.1007/BF01314374. [DOI] [PubMed] [Google Scholar]
  28. Oldstone M. B. Molecular mimicry and autoimmune disease. Cell. 1987 Sep 11;50(6):819–820. doi: 10.1016/0092-8674(87)90507-1. [DOI] [PubMed] [Google Scholar]
  29. Owen O. E., Cahill G. F., Jr Metabolic effects of exogenous glucocorticoids in fasted man. J Clin Invest. 1973 Oct;52(10):2596–2605. doi: 10.1172/JCI107452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Patrick S. L., Moy C. S., LaPorte R. E. The world of insulin-dependent diabetes mellitus: what international epidemiologic studies reveal about the etiology and natural history of IDDM. Diabetes Metab Rev. 1989 Nov;5(7):571–578. doi: 10.1002/dmr.5610050704. [DOI] [PubMed] [Google Scholar]
  31. Perlman K., Ehrlich R. M. Steroid diabetes in childhood. Am J Dis Child. 1982 Jan;136(1):64–68. doi: 10.1001/archpedi.1982.03970370066017. [DOI] [PubMed] [Google Scholar]
  32. Qin H. Y., Singh B. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J Autoimmun. 1997 Jun;10(3):271–278. doi: 10.1006/jaut.1997.0136. [DOI] [PubMed] [Google Scholar]
  33. Rabinovitch A., Suarez-Pinzon W. L., Sorensen O., Bleackley R. C., Power R. F. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol. 1995 May 1;154(9):4874–4882. [PubMed] [Google Scholar]
  34. Rothe H., Faust A., Schade U., Kleemann R., Bosse G., Hibino T., Martin S., Kolb H. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia. 1994 Nov;37(11):1154–1158. doi: 10.1007/BF00418380. [DOI] [PubMed] [Google Scholar]
  35. Schloot N. C., Roep B. O., Wegmann D. R., Yu L., Wang T. B., Eisenbarth G. S. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects. Diabetologia. 1997 Mar;40(3):332–338. doi: 10.1007/s001250050683. [DOI] [PubMed] [Google Scholar]
  36. Scott F. W. Food-induced type 1 diabetes in the BB rat. Diabetes Metab Rev. 1996 Dec;12(4):341–359. doi: 10.1002/(SICI)1099-0895(199612)12:4<341::AID-DMR173>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  37. See D. M., Tilles J. G. Pathogenesis of virus-induced diabetes in mice. J Infect Dis. 1995 May;171(5):1131–1138. doi: 10.1093/infdis/171.5.1131. [DOI] [PubMed] [Google Scholar]
  38. Shehadeh N. N., LaRosa F., Lafferty K. J. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun. 1993 Jun;6(3):291–300. doi: 10.1006/jaut.1993.1025. [DOI] [PubMed] [Google Scholar]
  39. Singh B., Prange S., Jevnikar A. M. Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus. Semin Immunol. 1998 Feb;10(1):79–86. doi: 10.1006/smim.1997.0107. [DOI] [PubMed] [Google Scholar]
  40. Songini M., Muntoni S. High incidence of type I diabetes in Sardinia. Lancet. 1991 Apr 27;337(8748):1047–1047. doi: 10.1016/0140-6736(91)92714-d. [DOI] [PubMed] [Google Scholar]
  41. Timperley A. C., Withnall R. D., Rainford D. J. The development of insulin-dependent diabetes mellitus in renal transplant patient receiving oral isotretinoin. Nephrol Dial Transplant. 1996 Apr;11(4):753–753. doi: 10.1093/oxfordjournals.ndt.a027388. [DOI] [PubMed] [Google Scholar]
  42. Wagner K., Webber S. A., Kurland G., Boyle G. J., Miller S. A., Cipriani L., Griffith B. P., Fricker F. J. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. J Heart Lung Transplant. 1997 Mar;16(3):275–282. [PubMed] [Google Scholar]
  43. Waguri M., Hanafusa T., Itoh N., Imagawa A., Miyagawa J., Kawata S., Kono N., Kuwajima M., Matsuzawa Y. Occurrence of IDDM during interferon therapy for chronic viral hepatitis. Diabetes Res Clin Pract. 1994 Feb;23(1):33–36. doi: 10.1016/0168-8227(94)90124-4. [DOI] [PubMed] [Google Scholar]
  44. Welsh N., Päbo S., Welsh M. Decreased mitochondrial gene expression in isolated islets of rats injected neonatally with streptozotocin. Diabetologia. 1991 Sep;34(9):626–631. doi: 10.1007/BF00400991. [DOI] [PubMed] [Google Scholar]
  45. Yale J. F., Chamelian M., Courchesne S., Vigeant C. Peripheral insulin resistance and decreased insulin secretion after cyclosporine A treatment. Transplant Proc. 1988 Jun;20(3 Suppl 3):985–988. [PubMed] [Google Scholar]
  46. Yasunami R., Bach J. F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol. 1988 Mar;18(3):481–484. doi: 10.1002/eji.1830180325. [DOI] [PubMed] [Google Scholar]
  47. Yoon J. W., Onodera T., Notkins A. L. Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4. J Exp Med. 1978 Oct 1;148(4):1068–1080. doi: 10.1084/jem.148.4.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. von Herrath M. G., Holz A., Homann D., Oldstone M. B. Role of viruses in type I diabetes. Semin Immunol. 1998 Feb;10(1):87–100. doi: 10.1006/smim.1997.0108. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES